BTIG maintains Veeva Systems at Buy, raises price target to $360 from $340

BTIG reaffirmed its Buy rating for Veeva Systems and increased its price target to $360 from $340, suggesting an 18.5% upside from the Nov 6 close of $303.73. Recent analyst price targets for the company range from $325 to $375.

Original reporting
Published Nov 9, 2026, 10:16 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 9, 2026, 10:26 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
BTIG maintains Veeva Systems at Buy, raises price target to $360 from $340 — source image
Decision brief

The 30-second read

$VEEVBullishMed
01

Why it matters

The target increase could attract short‑term buying interest but lacks a catalyst beyond the rating change.

02

Market read

A modest analyst upgrade that may nudge VEEV higher, but limited trading relevance.

03

What to watch

No new earnings or product news; the move relies solely on analyst opinion.

Relevance 7/10Novelty 6/10Timing: today

Background

BTIG's note is part of routine analyst coverage updates for Veeva Systems.

Company-level read

Ticker impact

$VEEVBullishMedium confidence
Context

BTIG raised its price target on Veeva Systems to $360 from $340, indicating a bullish analyst view.

Expected impact

likely upward pressure as investors price in the higher target

Evidence & confidence

Target raise of 5.9% signals confidence in earnings outlook; no new fundamental data, but analyst sentiment can move the stock.

Market effects

May lift sentiment in the cloud‑software sector as peers are re‑rated.

Limited to US equities; no broader regional effect.

Low; impact confined to VEEV and its immediate peers.

Counterpoint

Target raises can be premature; price may already reflect optimism.

Key entities

  • Veeva Systems

    Cloud‑based software provider for life‑sciences.

  • BTIG

    Equity research firm issuing the rating.

Related articles

$VEEVHigh

Wells Fargo raises Veeva Systems stock price target on AI growth

Wells Fargo raised its price target on Veeva Systems (VEEV) to $400 from $330, citing AI-driven growth. The stock trades at $305.55, with a 31% upside to the new target. Analysts project $1B in AI revenue by 2030, separate from its $6B core business. VEEV's revenue grew 16.5% over the last year, with strong profit margins. Multiple analysts have raised their price targets, reflecting optimism about Veeva's AI and cloud growth prospects.

$VEEVHigh

VEEVA SYSTEMS INC (VEEV): Total Revenue $932-935 million Subscription Revenue ~$782 million Services Revenue $150-153 million Non-GAAP Operating Income $417-420 million Non-GAAP Fully…

VEEVA SYSTEMS INC (VEEV) filed an SEC Form 8-K — Results of Operations and Financial Condition. Total Revenue $932-935 million Subscription Revenue ~$782 million Services Revenue $150-153 million Non-GAAP Operating Income $417-420 million Non-GAAP Fully Diluted Net Income per Share $2.33-2.34 Expect to Meet or Exceed Q3’27 Guidance Guidance issued on August 26, 2026. Our Q3

$VEEVHigh

Veeva Systems (VEEV) Stock Trades Up, Here Is Why

Veeva Systems (VEEV) stock rose 2.8% after expanding its partnership with IQVIA, which adopted Veeva's clinical operations software. The company reported Q2 revenue of $928M, up 17.6% YoY, beating estimates. VEEV raised full-year revenue guidance to $3.68B and adjusted earnings outlook to $9.21 per share. The stock is up 37% YTD and hit a 52-week high.

$VEEVMed

CFRA upgrades Veeva Systems (VEEV) to a Buy

CFRA upgraded Veeva Systems (VEEV) to Buy with a new price target. The consensus rating is Moderate Buy with an average target of $293.57. Veeva reported Q2 revenue of $927.96M and net profit of $273.43M, up from $789.08M and $200.31M last year. Insider sentiment is negative, with 63 insiders selling shares.

$VEEVMedAI 8/10

Veeva Rises on Sales and Margin Gains, Guidance Raise

Veeva Systems (VEEV) reported Q2 fiscal 2027 revenue of $928M, up 18% YoY, with non-GAAP operating income of $415.9M. The company raised guidance to $3.687B in revenue and $9.21 in non-GAAP EPS. VEEV shares have risen 25% YTD, supported by strong institutional demand and robust fundamentals, including 3-year sales and EPS growth rates of 14.1% and 21.6%, respectively.